Enalapril vs Angiotensin (1-7) — Peptide Comparison

Enalapril vs Angiotensin (1-7) — Peptide Comparison Enalapril vs Angiotensin (1-7) — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range Enalapril 2.5 mg–40 mg mg Angiotensin (1-7) 0.5-1 mcg/kg–5-10 mcg/kg mcg Frequency Once daily Administration Oral tablet As directed by healthcare provider Cycle Length Ongoing/indefinite Onset Speed Moderate (1-2 weeks) Evidence Level Strong human trials (Phase 3 or FDA approved) Moderate human trials (Phase 1-2) Efficacy Cardiovascular Health Long-term Protection Quality of Life Heart Health & Protection Blood Pressure Balance Anti-Inflammatory Support Technical Data Molecular Formula C20H28N2O5 Molecular Weight 376.4 g/mol Half-Life Enalapril: 1 hour; Enalaprilat (active form): 11 hours effective half-life Bioavailability Approximately 60% oral bioavailability when taken by mouth CAS Number 75847-73-3 C41H62N12O11 899.02 g/mol Approximately 2-6 hours (varies by route of administration) Varies by route of administration 25016-41-7 Protocols starting 2.5–5 mg Titrate over 1–2 weeks FDA-approved starting dose. For high blood pressure, begin at 5 mg once daily; for heart failure, begin lower at 2.5 mg to avoid a big drop in blood pressure [4]. standard 10–20 mg/day Once or twice daily Ongoing Usual blood-pressure maintenance dose, taken once daily or split into two doses. The dose is raised gradually based on response [4]. advanced 40 mg/day In two divided doses (20 mg twice daily) Maximum dose. For heart failure the target is 20 mg twice daily; for high blood pressure up to 40 mg/day is the ceiling [4]. 100 mcg/kg Once daily after each chemotherapy session Up to 6 chemotherapy cycles In a cancer trial, this dose was injected under the skin after chemo to help protect platelet counts. A higher 300 mcg/kg dose was also tested but did not work better. [4] 0.5 mg/kg Up to 10 days In a COVID-19 study, the lab-made form (called TXA-127) was given as a daily drip into a vein. No serious drug-related side effects were seen. [5] Applications Managing hypertension to prevent serious complications Enalapril is particularly well-suited for individuals focused on managing hypertension to prevent serious complications. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Treating heart failure and improving survival rates Enalapril is particularly well-suited for individuals focused on treating heart failure and improving survival rates. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Protecting organs from damage caused by high blood pressure Enalapril is particularly well-suited for individuals focused on protecting organs from damage caused by high blood pressure. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Cardiovascular health and heart protection Angiotensin (1-7) is particularly well-suited for individuals focused on cardiovascular health and heart protection. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Blood pressure management and hypertension Angiotensin (1-7) is particularly well-suited for individuals focused on blood pressure management and hypertension. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Recovery from heart-related conditions Angiotensin (1-7) is particularly well-suited for individuals focused on recovery from heart-related conditions. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Anti-inflammatory support Angiotensin (1-7) is particularly well-suited for individuals focused on anti-inflammatory support. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach. Safety Profile Common Dry cough Dizziness Fatigue Hyperkalemia Angioedema Serious Severe allergic reaction Hypotension (Low Blood Pressure) Dizziness or Lightheadedness Injection Site Reactions Headache Hyperkalemia (High Potassium) Research Status FDA Status FDA approved for this use Safety Overview Enalapril is an FDA-approved ACE inhibitor with safety data spanning over 40 years of clinical use and post-market surveillance in millions of hypertensive patients. Persistent dry cough occurs in 10-20% of patients, caused by kinase II inhibition and bradykinin accumulation. Hyperkalemia is a serious risk, particularly in renal impairment, diabetes, or concurrent NSAID/potassium-sparing diuretic use—potassium monitoring is essential. Angioedema (0.1-0.2%) is a rare but life-threatening emergency, absolute contraindication for future ACE inhibitor use. Hypotension can occur in volume-depleted patients or those on concurrent vasodilators. Acute kidney injury risk exists in patients with bilateral renal artery stenosis or single kidney. Fetal teratogenicity is well-documented in pregnancy. Contraindications xPregnancy (causes serious fetal harm) xHistory of angioedema with ACE inhibitors xSevere renal dysfunction xConcurrent use with certain other blood pressure medications xPotassium supplementation without medical supervision Research compound Angiotensin (1-7) is not FDA-approved and has no completed human clinical trials, with all safety data limited to animal studies and in vitro mechanistic work. Animal studies suggest potential benefits in hypertension and cardiac remodeling but also reveal risks of hypotension, particularly with concurrent ACE inhibitor or ARB therapy. The peptide's effects on systemic inflammation and immune function in animal models are not validated in humans. No pharmacokinetic data exists defining safe doses, optimal delivery routes, or organ accumulation patterns in humans. xSevere hypotension or uncontrolled low blood pressure xAcute myocardial infarction in early stages xConcurrent use with certain ACE inhibitors without medical supervision xPregnancy and breastfeeding (insufficient safety data) Decision Guide Choose Enalapril if... Managing hypertension to prevent serious complications Treating heart failure and improving survival rates Protecting organs from damage caused by high blood pressure Choose Angiotensin (1-7) if... Cardiovascular health and heart protection Blood pressure management and hypertension Recovery from heart-related conditions Anti-inflammatory support